A pooled Cell Painting CRISPR screening platform enables de novo inference of gene function by self-supervised deep learning.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41402283.
- Also identified by DOI 10.1038/s41467-025-66778-6 and PMC identifier 12770385.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Pooled CRISPR screening enables large-scale interrogation of gene functions but typically measures simple phenotypes such as fitness. High-content methods like Perturb-seq extend dimensionality to transcriptomics but are costly and limited in scope. Optical pooled screening (OPS) combines pooled CRISPR screening with imaging to yield scalable, information-rich readouts, yet existing implementations remain pathway-specific. Here we describe an OPS-compatible Cell Painting platform that enables hypothesis-free reverse genetic screening through multiplexed morphological profiling. We validate this technique using a well-defined morphological gene set, compare classical image analysis to self-supervised learning methods using a mechanism-of-action library, and perform discovery screening with a druggable genome library. By combining rich morphological data with deep learning, gene networks emerge without the need for target-specific biomarkers, leading to unbiased discovery of gene functions.
Medical subject headings
- Deep Learning
- CRISPR-Cas Systems
- Clustered Regularly Interspaced Short Palindromic Repeats